Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chemical Agents for Microbial Control01:27

Chemical Agents for Microbial Control

771
Chemicals play important roles in controlling microbial growth by targeting microbial structures and functions as sanitizers, antiseptics, disinfectants, and sterilants.Alcohols are commonly used sanitizers, effectively disrupting lipid membranes, which compromises cell integrity. They are also used as antiseptics and disinfectants due to their rapid action and versatility.Phenols and their derivatives phenolics , known for denaturing proteins and disrupting cell membranes, are particularly...
771
Subviral Agents01:29

Subviral Agents

544
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
544
Air-entraining Agents01:27

Air-entraining Agents

260
Air-entraining agents improve the durability and workability of concrete in climates with frequent freezing and thawing. These agents prevent cracks by introducing small air bubbles into the mix, creating spaces accommodating water expansion when temperatures drop. The air-entraining agents lower the surface tension of water, forming stable, small air bubbles. This method is more effective than having accidental large voids, as the intentional, smaller, and evenly distributed air voids improve...
260
Masking and Demasking Agents01:19

Masking and Demasking Agents

3.5K
EDTA titrations may necessitate masking and demasking agents to temporarily protect a particular metal ion in a mixture from the EDTA reaction. These agents facilitate the sequential analysis of the metal ions by forming stable complexes with some—but not all—metal ions during certain steps.
There are many masking agents, such as cyanide, fluoride, triethanolamine, thiourea, and 2,3-bis(sulfanyl)propan-1-ol (formerly 2,3-dimercapto-1-propanol), with the masking agent chosen based on...
3.5K
Oral Hypoglycemic Agents: Glinides01:06

Oral Hypoglycemic Agents: Glinides

608
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
608
Spasmolytic Agents: Chemical Classification01:29

Spasmolytic Agents: Chemical Classification

1.3K
Spasmolytic agents are drugs used to alleviate muscle spasms and spasticity. They can be categorized into different chemical groups based on their mechanisms of action. Centrally acting spasmolytics primarily affect the spinal cord, while others directly target skeletal muscle cells.
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of Bipyridine and Phenanthroline Incorporation into the Macropa Scaffold on Ba(II)/Ra(II) Chelation.

Inorganic chemistry·2026
Same author

Understanding Online Health Information Consumption Through Web Analytics of the Italian Society of Pharmacology Magazine: 3-Year Descriptive Analysis.

JMIR formative research·2026
Same author

The crucial role of acetonitrile in the mechanism of Pd(II)-catalyzed activation of polar vinyl monomers.

Dalton transactions (Cambridge, England : 2003)·2025
Same author

TRASUTA: The Effect of the Structural Rigidity of a Mesocyclic AAZTA-like Chelating Agent on the Thermodynamic, Kinetic, and Structural Properties of Some Divalent Metal and Ga<sup>3+</sup> Complexes.

Inorganic chemistry·2024
Same author

[Gd(HB-DO3A)]: Equilibrium, Dissociation Kinetic and Structural Differences in a Simple Homolog of [Gd(HP-DO3A)] (Prohance<sup>®</sup>).

Chemistry (Weinheim an der Bergstrasse, Germany)·2024
Same author

Lysozyme: A Natural Product with Multiple and Useful Antiviral Properties.

Molecules (Basel, Switzerland)·2024

Related Experiment Video

Updated: Jan 22, 2026

Synthesis and Evaluation of a Ruthenium-based Mitochondrial Calcium Uptake Inhibitor
07:12

Synthesis and Evaluation of a Ruthenium-based Mitochondrial Calcium Uptake Inhibitor

Published on: October 26, 2017

8.2K

Ruthenium antimetastatic agents.

Enzo Alessio1, Giovanni Mestroni, Alberta Bergamo

  • 1Department of Chemical Sciences, University of Trieste, Via L. Giorgieri 1, 34127 Trieste, Italy. alessi@univ.trieste.it

Current Topics in Medicinal Chemistry
|December 8, 2004
PubMed
Summary

Ruthenium complexes, like NAMI-A, show promise against cancer metastasis. New derivatives maintain or improve antimetastatic activity by affecting tumor invasion and cell cycle, though their precise targets remain elusive.

More Related Videos

Preparation and In Vitro Characterization of Dendrimer-based Contrast Agents for Magnetic Resonance Imaging
11:27

Preparation and In Vitro Characterization of Dendrimer-based Contrast Agents for Magnetic Resonance Imaging

Published on: December 4, 2016

10.5K
The Synthesis, Characterization and Reactivity of a Series of Ruthenium N-triphosPh Complexes
10:51

The Synthesis, Characterization and Reactivity of a Series of Ruthenium N-triphosPh Complexes

Published on: April 10, 2015

12.7K

Related Experiment Videos

Last Updated: Jan 22, 2026

Synthesis and Evaluation of a Ruthenium-based Mitochondrial Calcium Uptake Inhibitor
07:12

Synthesis and Evaluation of a Ruthenium-based Mitochondrial Calcium Uptake Inhibitor

Published on: October 26, 2017

8.2K
Preparation and In Vitro Characterization of Dendrimer-based Contrast Agents for Magnetic Resonance Imaging
11:27

Preparation and In Vitro Characterization of Dendrimer-based Contrast Agents for Magnetic Resonance Imaging

Published on: December 4, 2016

10.5K
The Synthesis, Characterization and Reactivity of a Series of Ruthenium N-triphosPh Complexes
10:51

The Synthesis, Characterization and Reactivity of a Series of Ruthenium N-triphosPh Complexes

Published on: April 10, 2015

12.7K

Area of Science:

  • Inorganic Chemistry
  • Medicinal Chemistry
  • Pharmacology

Background:

  • NAMI-A, a Ruthenium(III) complex, has demonstrated significant preclinical antimetastatic activity.
  • NAMI-A is the first ruthenium complex to successfully complete a Phase I clinical trial.

Purpose of the Study:

  • To review the chemical and pharmacological aspects of NAMI-A.
  • To explore the development of new ruthenium complexes derived from the NAMI-A framework.
  • To investigate the antimetastatic potential of novel NAMI-A-type compounds.

Main Methods:

  • Synthesis and characterization of NAMI-A-type complexes, dinuclear compounds, and Ru-dmso nitrosyls.
  • Evaluation of antimetastatic activity of new ruthenium complexes.
  • Assessment of cytotoxicity and impact on metastasis-related parameters (e.g., tumor invasion, matrix metalloproteinases, cell cycle).

Main Results:

  • Several new NAMI-A-type compounds exhibit antimetastatic activity comparable to or exceeding NAMI-A.
  • The precise molecular targets responsible for the antimetastatic effects are yet to be identified.
  • Low cell cytotoxicity does not fully explain the potent antimetastatic activity of these compounds.

Conclusions:

  • NAMI-A-type compounds, including monomeric and dimeric forms, possess significant antimetastatic potential.
  • These ruthenium complexes modulate key metastatic processes like tumor invasion and matrix metalloproteinase activity.
  • Further research is needed to elucidate the specific mechanisms underlying their antitumor effects.